Multivariate analysis confirmed that MTA3 expression independently affects prognosis, with predictive power comparable to established factors, including tumor differentiation grade, depth of invasion, lymph node metastasis, and TNM stage. The gene discussed is MTA3; the disease is metastatic malignant neoplasm in the lymph nodes.